IgA nephropathy in renal allografts-recurrence and graft dysfunction

Yonsei Medical Journal

Volumn 45, Issue 6, 2004, Pages 1043-1048

  Jeong, Hyeon Joo ^a   Huh, Kyu Ha ^a   Kim, Yu Seun ^a   Kim, Soon Il ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Histology; IgA nephropathy; Proteinuria; Recurrence; Renal transplantation

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A;

CLINICAL FEATURE; GLOMERULOSCLEROSIS; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RECURRENT DISEASE; RENAL GRAFT DYSFUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 12344317058     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.6.1043     Document Type: Review

References (48)

1. Berger J, Yaneva H, Nabarra B, Barbanel C. Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 1975;7:232-41.
2. Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1988;12:371-2.
3. Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994;9:309-12.
4. Kessler M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 1996;28:99-104.
5. Frohnert PP, Donadio JV, Velosa JA, Holley KE, Sterioff S. The fate of renal transplants in patients wit IgA nephropathy. Clin Transplant 1997;11:127-33.
6. Ohmacht C, Kliem V, Burg M, Nashan B, Schlitt HJ, Brunkhorst R, et al. Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. Transplantation 1997;64:1493-6.
7. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998;65:1053-60.
8. Floege J, Burg M, Kliem V. Recurrent IgA nephropathy after kidney transplantation: not a benign condition. Nephrol Dial Transplant 1998;13:1933-5.
9. Choy BY, Chan TM, Lo SK, Lo WK, Lai KN. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003; 18:2399-404.
10. Hariharan S, Peddi VR, Savin VJ, Johnson CP, First MR, Roza AH, et al. Recurrent and de novo renal disease after renal transplantation: A report from the renal allograft disease registry. Am J Kidney Dis 1998;31:928-31.
11. Chadban SJ. Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 2001;12:394-402.
12. Jeong HJ, Hong SW, Kim YS, Kim SI, Kim MS, Choi KH, et al. Histologic factors associated with nephrotic range proteinuria in recurrent IgA nephropathy. Transplant Proc 2003;35:291.
13. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001;60: 1948-54.
14. Kim YS, Moon JI, Jeong HJ, Kim MS, Kim SI, Choi KH, et al. Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephropathy. Transplantation 2001;71:233-8.
15. Freese P, Svalander C, Norden G, Nyberg G. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 1999;13:313-7.
16. Schwartz A, Krause PH, Offermann G, Keller F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991;17:524-31.
17. Kim YS, Jeong JH, Kim MS, Kim SI, Han DS, Park K. Is kidney graft biopsy indicated in recipients with newly developed, microscopic hematuria? Clin Transplant 1998;12:104-8.
18. Bachman U, Biava C, Amend W, Feduska N, Melzer J, Salvatierra O, et al. The clinical course of IgA-nephropathy and Henoch-Schonlein purpura following renal transplantation. Transplantation 1986;42:511-5.
19. Andresdottir MB, Hoitsma AJ, Assmann KJM, Wetzels JFM. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 2001;56: 279-88.
20. Wang AYM, Lai FM, Yu AW-Y, Lam PK, Chow KM, Choi PC, et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 2001;38:588-96.
21. Brensilver JM, Mallat S, Scholes J, McCabe R. Recurrent IgA nephropathy in living-related donor transplantation: Recurrence or transmission of familial disease? Am J Kidney Dis 1988;12:147-51.
22. Donadio Jr JV, Grande JP. Immunoglobulin A nephropathy: a clinical perspective. J Am Soc Nephrol 1997;8:1324-32.
23. Tolkoff-Rubin NE, Cosimi AB, Fuller T, Rubin RH, Colvin RB. IgA nephropathy in HLA-identical siblings. Transplantation 1978;26:431-3.
24. Tomlanovich S, Vincenti F, Amend W, Biava C, Melzer J, Feduska N, et al. Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation? Transplant Proc 1988;20:285-8.
25. Berthoux F, Diconne E, Mariat C, Thibaudin D, Alamartine E, De Filippis JP, et al. Risk factors for primary IgA nephropathy (IgAN) recurrence after renal transplantation (RTX) (abstract). Nephrol Dial Transplant 2003;18 (Suppl 4):801.
26. Coppo R, Amore A, Cirina P, Messina M, Basolo B, Segoloni G, et al. IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. Nephrol Dial Transplant 1995;10:2310-5.
27. Nowak R, Birck R, van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy (letter). Lancet 1997;349:774.
28. Lim EC, Terasaki PI. High survival of kidney transplants in IgA nephropathy patients. Clin Transplant 1992;6:100-5.
29. Freese P, Norden G, Olausson M, Nyberg G. Rejection rates in kidney transplant patients with and without IgA nephropathy. Nephrol Dial Transplant 1997;12: 2385-8.
30. Alamantine E, Boulharouz J, Berthoux F. Actuarial survival rate of kidney transplants in patients with IgA glomerulonephritis: A one-center study. Transplant Proc 1994;26:272.
31. Sumethkul V, Jirasiritham S, Chalermsanyakorn P, Buranachokpaisan W. Chronic rejection: a significant predictor of poor outcome for recurrence IgA nephropathy. Transplant Proc 2001;33:3375-6.
32. Sakurai T, Okamoto N, Fukuzawa S, Sirosita K, Ueda T, Hirano T. Is IgA nephropathy in renal transplants a risk leading to graft failure? Transplant Proc 1999;31: 2651-4.
33. Pettersson E, Honkanen E, Tornroth T. Recurrence of IgA nephropathy with nephrotic syndrome in renal allograft. Nephron 1985;41:114-7.
34. Marcen R, Pascual J, Felipe C, Mampaso F, Gonzalo A, Orofino L, et al. Recurrence of IgA nephropathy with nephrotic syndrome after kidney transplantation. Nephron 1991;59:486-9.
35. Lim EC, Chia D, Gjertson DW, Koka P, Terasaki PI. In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 1993;55: 996-9.
36. Chikamoto H, Hattori M, Horita S, Sawai T, Ohmori T, Ogino D, et al. A clinicopathological study of recurrent IgA nephropathy following renal transplantation in children. Nephrology 2003;8:A115.
37. Diaz-Tejeiro R, Maduell F, Diez J, Esparza N, Errasti P, Purroy A, et al. Loss of renal graft due to recurrent IgA nephropathy with rapidly progressive course: an unusual clinical evolution. Nephron 1990;54:341-3.
38. Robles NR, Gomez Campdera FJ, Anaya F, Niembro De Rasche E, Galan A, Rengel MA, et al. IgA nephropathy with rapidly progressive course after kidney transplantation. Nephron 1991;58:487-8.
39. Streather CP, Scoble JE. Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis. Nephron 1994;66:113-4.
40. Park SB, Joo I, Suk J, Cho WH, Park CH, Kim SP, et al. Rapidly progressive glomerulonephritis, in a renal transplant with recurrent IgA nephropathy. Transplant Proc 1996;28:1529-30.
41. Benabdallah L, Rerolle JP, Peraldi MN, Noel LH, Bruneel MF, Carron PL, et al. An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy. Am J Kidney Dis 2002;40:E20.
42. Kim YS, Jeong HJ, Kwon KW, Lee HY, Han DS, Park K. Live donor renal transplantation in patients with end-stage renal failure due to IgA nephropathy: clinicopathological assessment. Nephrology 2002;7:S74-7.
43. Jeong HJ, Kim YS, Kwon KW, Kim MS, Kim SI, Choi KH, et al. Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: Relationship with proteinuria and therapeutic response to enalapril. Clin Transplant 2003;17:108-13.
44. Oka K, Imai E, Moriyama T, Akagi Y, Ando, A, Hori M, et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant 2000;15:689-95.
45. Kimata N, Tanabe K, Ishikawa N, Ozu H, Sonda K, Yumura W, et al. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc 1996;28:1537-9.
46. Barnas U, Mayer G. Glomerular proteinuria in renal transplant patients: Mechanisms and treatment. Kidney Int 1997;52 Suppl 63:S78-80.
47. Rosenkranz AR, Mayer G. Proteinuria in the transplanted patient. Nephrol Dial Transplant 2000;15:1290-2.
48. Jeong HJ, Kim YS, Kwon KH, Kim SI, Kim MS, Choi KH, et al. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy. Pathology Int 2004;54:772-7.